Eyenovia Inc (EYEN)
0.1019
-0.24
(-70.04%)
USD |
NASDAQ |
Nov 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Debt to Equity Ratio: -5.940 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -5.940 |
| March 31, 2024 | 8.205 |
| December 31, 2023 | 1.588 |
| September 30, 2023 | 0.8937 |
| June 30, 2023 | 1.342 |
| March 31, 2023 | 0.5937 |
| December 31, 2022 | 0.5066 |
| September 30, 2022 | 0.3556 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3147 |
| March 31, 2022 | 0.2598 |
| December 31, 2021 | 0.3494 |
| September 30, 2021 | 1.715 |
| June 30, 2021 | 0.8848 |
| March 31, 2021 | 0.0899 |
| December 31, 2020 | 0.0303 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.940
Minimum
Jun 2024
8.205
Maximum
Mar 2024
0.7459
Average
0.5066
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| TFF Pharmaceuticals Inc | 0.00 |
| Reviva Pharmaceuticals Holdings Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.00M |
| Total Liabilities (Quarterly) | 21.36M |
| Shareholders Equity (Quarterly) | -2.370M |
| Current Ratio | 0.4596 |
| Net Debt Paydown Yield | -2.83% |